Zobrazeno 1 - 10 of 29 pro vyhledávání: '"A C, Achhra"'
1
Contrasting Cases of HIV Vasculopathy Associated Fusiform Aneurysms
Autor: Kevin Kyle, Mary Maher, Amit C. Achhra, Nagagopal Venna
Publikováno v: The Neurohospitalist. 13:69-73
Background Human Immunodeficiency Virus (HIV) vasculopathy encompasses the development of aneurysms, stenosis and vessel occlusions. Intracranial fusiform aneurysms in Human Immunodeficiency Virus (HIV) were originally described in children; however,
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1cef1b473d975191211ae50fa89eb8
https://doi.org/10.1177/19418744221122863
Zobrazit plný text záznamu
2
Akademický článek
Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial
Autor: Jason V. Baker, Shweta Sharma, Amit C. Achhra, Jose Ignacio Bernardino, Johannes R. Bogner, Daniel Duprez, Sean Emery, Brian Gazzard, Jonathan Gordin, Greg Grandits, Andrew N. Phillips, Siegfried Schwarze, Elsayed Z. Soliman, Stephen A. Spector, Giuseppe Tambussi, Jens Lundgren
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 6, Iss 5 (2017)
IntroductionHIV infection and certain antiretroviral therapy (ART) medications increase atherosclerotic cardiovascular disease risk, mediated, in part, through traditional cardiovascular disease risk factors. Methods and ResultsWe studied cardiovascu
Externí odkaz: https://doaj.org/article/35e91ffef11d486f987d85afac712f53
Zobrazit plný text záznamu
3
Assessing Cardiovascular Risk in People Living with HIV: Current Tools and Limitations
Autor: Ralph B. D'Agostino, Amit C. Achhra, Milana Bogorodskaya, Jorge Plutzky, Leila H. Borowsky, Asya Lyass, Virginia A. Triant, Joseph M. Massaro
Publikováno v: Curr HIV/AIDS Rep
PURPOSE OF REVIEW: To provide the current state of the development and application of cardiovascular disease (CVD) prediction tools in people living with HIV (PLWH). RECENT FINDINGS: Several risk prediction models developed on the general population
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b5642324f567781e855ff7e29b80d96
https://europepmc.org/articles/PMC8733948/
Zobrazit plný text záznamu
4
Akademický článek
Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trial.
Autor: Amit C Achhra, Mark A Boyd, Matthew G Law, Gail V Matthews, Anthony D Kelleher, David A Cooper
Publikováno v: PLoS ONE, Vol 9, Iss 6, p e99530 (2014)
Regimens sparing RATE (ritonavir, abacavir, tenofovir, efavirienz) agents might have better long-term safety. We conducted a feasibility exercise to assess the potential for a randomised trial evaluating RATE-sparing regimens.Observational.We first c
Externí odkaz: https://doaj.org/article/f415e03257754b62adda85a06c7b8973
Zobrazit plný text záznamu
5
Akademický článek
Differences in Lipid Measurements by Antiretroviral Regimen Exposure in Cohorts from Asia and Australia
Autor: Amit C. Achhra, Janaki Amin, Jennifer Hoy, Junko Tanuma, Thira Sirisanthana, David Nolan, Tuti Merati, Michelle Giles
Publikováno v: AIDS Research and Treatment, Vol 2012 (2012)
We explored the mean differences in routinely measured lipids (total cholesterol, triglycerides, and high-density lipoprotein cholesterol) according to exposure to different combination antiretroviral regimens in Asian (n=2051) and Australian (predom
Externí odkaz: https://doaj.org/article/b56e06215b0d443da3ba4895f24ec621
Zobrazit plný text záznamu
6
Efficacy and safety of contemporary dual-drug antiretroviral regimens as first-line treatment or as a simplification strategy: a systematic review and meta-analysis
Autor: Amit C. Achhra, Janaki Amin, Gwamaka Eliudi Mwasakifwa, Mark A. Boyd
Publikováno v: The Lancet HIV. 3:e351-e360
Summary Background Some guidelines recommended two-drug antiretroviral therapies as alternative regimens to triple therapy in selected patients with the aim of reducing drug burden and toxicity and preserving future treatment options. We aimed to ass
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::260d1d0f11f847d454362f14554bec06
https://doi.org/10.1016/s2352-3018(16)30015-7
Zobrazit plný text záznamu
7
Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
Autor: Matthew Law, Nathalie de Rekeneire, Andreas D Haas, Marco Tulio Luque, Paula Braitstein, Alison G. Abraham, Catherine C. McGowan, Kara Wools-Kaloustian, Michael Gill, Michelle L. Giles, Morna Cornell, Renaud Becquet, Man Po Lee, Amit C. Achhra
Publikováno v: Journal of the International AIDS Society
Journal of the International AIDS Society, BioMed Central (2008-2012) ; International Aids Society (2008-) ; Wiley (2017-), 2018, 21 (6), pp.e25149. ⟨10.1002/jia2.25149⟩
Giles, Michelle L; Achhra, Amit C; Abraham, Alison G; Haas, Andreas D; Gill, Michael John; Lee, Man Po; Luque, Marco; McGowan, Catherine; Cornell, Morna; Braitstein, Paula; de Rekeneire, Nathalie; Becquet, Renaud; Wools-Kaloustian, Kara; Law, Matthew (2018). Sex-based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA). Journal of the International AIDS Society, 21(6), e25149. BioMed Central 10.1002/jia2.25149
International audience; INTRODUCTION: In 2015, the World Health Organization recommended that all HIV-infected individuals consider ART initiation as soon as possible after diagnosis. Sex differences in choice of initial ART regimen, indications for
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1d56b511f97bb32979db30636c3e3c
https://hal.archives-ouvertes.fr/hal-02998228
Zobrazit plný text záznamu
8
Body Mass Index and The Risk of Serious Non-Aids Events and All Cause Mortality in Treated Hiv-Positive Individuals: D: A: D Cohort Analysis
Autor: Amanda Mocroft, Christian Pradier, Jens D Lundgren, Andrew N. Phillips, Lene Ryom, Amit C. Achhra, Camilla Ingrid Hatleberg, Monforte Antonella D'Aminio, Fabrice Bonnet, Peter Reiss, Caroline A. Sabin, Stéphane De Wit, Wafaa El-Sadr, Matthew Law, Rainer Weber
Publikováno v: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 78(5), 579-588. Lippincott Williams and Wilkins
Background: The relationship between body mass index (BMI) [weight (kg)/height (m 2)] and serious non-AIDS events is not well understood. Methods: We followed D:A:D study participants on antiretroviral therapy from their first BMI measurement to the
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90a0323d83a1322ce02610b260792594
https://doi.org/10.5167/uzh-151844
Zobrazit plný text záznamu
9
Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy
Autor: Hansjakob Furrer, S De Wit, Matthew Law, Amit C. Achhra, M. H. Losso, Sean Emery, Andrew N. Phillips, Rodger D. MacArthur
Publikováno v: HIV Medicine. 16:449-454
OBJECTIVES Pre-antiretroviral therapy (ART) inflammation and coagulation activation predict clinical outcomes in HIV-positive individuals. We assessed whether pre-ART inflammatory marker levels predicted the CD4 count response to ART. METHODS Analyse
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7f7113a0a4306ee1b1b39006ae18e575
https://doi.org/10.1111/hiv.12258
Zobrazit plný text záznamu
10
Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial
Autor: Steven G. Deeks, Matthew Law, Matti Ristola, Brian Gazzard, Richard M. Novak, Stephen A. Migueles, Amit C. Achhra
Publikováno v: HIV Medicine. 16:37-45
Objectives A small subset of HIV-positive adults have low HIV RNA in the absence of therapy, sometimes for years. Clinical factors associated with low HIV RNA in early infection have not been well defined.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e8eae320c6f3303a58997de4e960fa3
https://doi.org/10.1111/hiv.12232
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje